← Back to guidelines
Cardiology19 papers

Structural abnormality of cardiac atrium

Last edited: 4/22/2026

Overview

Structural abnormalities of the cardiac atrium encompass congenital defects like atrial septal defects (ASD) and can lead to complications such as malpositioned pacemaker leads and associated valvular injuries 1.

Diagnosis

  • Echocardiography: Essential for identifying atrial defects and assessing related complications like lead malposition and valvular injury 1.
  • BNP/NT-proBNP Levels: Useful in asymptomatic hypertensive patients to detect underlying cardiac structural disease, though not specific to atrial abnormalities 2.
  • Clinical Symptoms: Dyspnea, fever, and signs of heart failure may indicate complications 1.
  • Management

  • Surgical Intervention: Recommended for complex cases involving lead removal, valvular repair, and defect closure 1.
  • Percutaneous Lead Removal: Considered risky due to potential thromboembolic events and infective endocarditis; reserved for less complex scenarios 1.
  • Monitoring: Regular echocardiographic follow-up to assess structural changes and device-related issues 1.
  • Special Populations

  • Pregnancy: Management requires careful consideration of peripartum pathophysiology; specific guidelines are recommended but not detailed in provided abstracts 3.
  • Elderly: Increased risk of complications; individualized care plans are necessary 1.
  • Comorbidities: Hypertension may necessitate monitoring BNP/NT-proBNP levels to detect cardiac structural changes 2.
  • Key Recommendations

  • Surgical Removal and Repair for Complex Lead Malpositions: Perform surgical extraction of malpositioned leads and repair associated defects when percutaneous methods pose significant risks (Evidence: Expert opinion 1).
  • Echocardiography for Diagnosis and Monitoring: Utilize echocardiography for diagnosing atrial structural abnormalities and monitoring complications (Evidence: Moderate 1).
  • Consider BNP/NT-proBNP in Asymptomatic Hypertensive Patients: Measure BNP/NT-proBNP levels to screen for underlying cardiac structural disease in asymptomatic hypertensive patients (Evidence: Moderate 2).
  • References

    1 Seki H, Fukui T, Shimokawa T, Manabe S, Watanabe Y, Chino K et al.. Malpositioning of a pacemaker lead to the left ventricle accompanied by posterior mitral leaflet injury. Interactive cardiovascular and thoracic surgery 2009. link 2 Mueller T, Gegenhuber A, Dieplinger B, Poelz W, Haltmayer M. Capability of B-type natriuretic peptide (BNP) and amino-terminal proBNP as indicators of cardiac structural disease in asymptomatic patients with systemic arterial hypertension. Clinical chemistry 2005. link 3 Clark SL. Labor and delivery in the patient with structural cardiac disease. Clinics in perinatology 1986. link

    Original source

    1. [1]
      Malpositioning of a pacemaker lead to the left ventricle accompanied by posterior mitral leaflet injury.Seki H, Fukui T, Shimokawa T, Manabe S, Watanabe Y, Chino K et al. Interactive cardiovascular and thoracic surgery (2009)
    2. [2]
    3. [3]
      Labor and delivery in the patient with structural cardiac disease.Clark SL Clinics in perinatology (1986)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG